Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barry S Taylor

Showing results (71-80 of 144) with videos related to

Pageof 15
Sort By:
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Nature Communications|April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivitiesTripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
JCO Precision Oncology|July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket StudyLillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
NPJ Precision Oncology|February 14, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapyCharlotte S Walmsley, Philip Jonsson, Michael L Cheng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Cancer Research|June 4, 2016
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome InhibitorsNeerav Shukla, Romel Somwar, Roger S Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Leukemia|February 19, 2020
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemiaAnica M Wandler, Benjamin J Huang, Jeffrey W Craig, et al.
Pageof 15

Showing results (71-80 of 144) with videos related to

Sort By:
Pageof 15
Nature Genetics|July 18, 2018
Genome doubling shapes the evolution and prognosis of advanced cancersCraig M Bielski, Ahmet Zehir, Alexander V Penson, et al.
Nature Communications|April 20, 2022
AKT mutant allele-specific activation dictates pharmacologic sensitivitiesTripti Shrestha Bhattarai, Tambudzai Shamu, Alexander N Gorelick, et al.
JCO Precision Oncology|July 12, 2021
Utility of Serial cfDNA NGS for Prospective Genomic Analysis of Patients on a Phase I Basket StudyLillian M Smyth, Jonathan B Reichel, Jiabin Tang, et al.
NPJ Precision Oncology|February 14, 2024
Convergent evolution of BRCA2 reversion mutations under therapeutic pressure by PARP inhibition and platinum chemotherapyCharlotte S Walmsley, Philip Jonsson, Michael L Cheng, et al.
Cancer Cell|November 6, 2018
Widespread Selection for Oncogenic Mutant Allele Imbalance in CancerCraig M Bielski, Mark T A Donoghue, Mayur Gadiya, et al.
Cancer Discovery|February 14, 2012
Genomic complexity and AKT dependence in serous ovarian cancerAphrothiti J Hanrahan, Nikolaus Schultz, Maggie L Westfal, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Cancer Research|June 4, 2016
Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome InhibitorsNeerav Shukla, Romel Somwar, Roger S Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancerGopa Iyer, Hikmat Al-Ahmadie, Nikolaus Schultz, et al.
Leukemia|February 19, 2020
Loss of glucocorticoid receptor expression mediates in vivo dexamethasone resistance in T-cell acute lymphoblastic leukemiaAnica M Wandler, Benjamin J Huang, Jeffrey W Craig, et al.
Pageof 15